Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Debridement & negative-pressure wound therapy · Alaska | Debridement & negative-pressure wound therapy · Alabama | |
|---|---|---|
| Surgeons, 2024 | 11 | 164 |
| Medicare fee-for-service cases | 2,366 | 36,065 |
| Growth since 2019 (Medicare FFS) | −11%/yr | −4.8%/yr |
| Forecast cases (Medicare FFS) | 2,680 in 2030 | 39,500 in 2030 |
| Forecast growth | +2.1%/yr to 2030 | +1.5%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 19.6 | 77.6 |
| Medicare Advantage share | 3% | 64% |
| Out of hospital | 19% (−12 pts since 2019) | 30% (+2 pts since 2019) |
| Cases per surgeon | 215 | 220 |
| Top 10 surgeons' share | 99% | 28% |
| Surgeons growing | 0 | 37 |
| New since the base year | 7 | 53 |
| Likely to stop billing it | 2 by 2026 | 22 by 2026 |
| Forecast miss, 1 year (procedure) | 3% | 3% |
| Company payments per surgeon | $3,931 | $877 |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.